(Q40538595)

21 September 2017

1 reference

title

Oxidative stress in Parkinson's disease (English)

1 reference

21 September 2017

1 reference

Schapira AH

1

1 reference

21 September 2017

1 February 1995

1 reference

Neuropathology and Applied Neurobiology

21 September 2017

1 reference

21 September 2017

21

1 reference

21 September 2017

1

1 reference

21 September 2017

3-9

1 reference

Brain Peroxidase and Catalase in Parkinson Disease

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Sequential damage in mitochondrial complexes by peroxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

The free radical hypothesis in idiopathic parkinsonism: evidence against it

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Increased nigral iron content in postmortem parkinsonian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Decreased ferritin levels in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Alpha-tocopherol levels in brain are not altered in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Photolabelling of a mitochondrially encoded subunit of NADH dehydrogenase with [3H]dihydrorotenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

A large kindred with autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Respiratory activity of isolated rat brain mitochondria following in vitro exposure to oxygen radicals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Twin studies and the genetics of Parkinson's disease--a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Glutathione peroxidase activity in Parkinson's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

When did Ray Kennedy's Parkinson's disease begin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Quantitation of a mitochondrial DNA deletion in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Rate of cell death in parkinsonism indicates active neuropathological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Neurotoxicity of levodopa on catecholamine-rich neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Alteration of inner-membrane components and damage to electron-transfer activities of bovine heart submitochondrial particles induced by NADPH-dependent lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Parkinson's disease: a disorder due to nigral glutathione deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l-DOPA and Carbidopa Chronically

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH–ubiquinone reductase preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

The possible role of iron in the etiopathology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.1995.TB01022.X

10.1111/J.1365-2990.1995.TB01022.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7770118